Toronto, Ontario--(Newsfile Corp. - October 18, 2018) - Canntab Therapeutics Limited (CSE: PILL) ("Canntab" or the
"Company") a leader in the development of precision oral dose cannabis tablets and capsules, is pleased to announce that it
has filed an application to become a Licensed Producer under the Access to Cannabis for Medical Purposes Regulations (the
"License"), and that it received confirmation from Health Canada that its application had been received. The License, if
granted by Health Canada, would allow the Company to process cannabis products at its current production facility in Markham,
Ontario with minimal additional capital expenditures as compared to a new purpose-built facility.
"We are excited to announce, as we enter into a new era of legalization, that Canntab has submitted its application to Health
Canada to become a Licensed Producer. This is another step that enables Canntab to further diversify its manufacturing and
distribution capabilities towards a world-wide rollout of its suite of precision oral dose delivery platforms for cannabis-based
products," said Jeff Renwick, CEO and a director of Canntab.
About Canntab
Canntab Therapeutics Limited is a Canadian cannabis oral dosage formulation company based in Markham Ontario, engaged in the
research and development of advanced pharmaceutical grade formulations of cannabinoids. Canntab has developed patented technology
to deliver standardized medical cannabis extract from selective strains in a variety of extended/sustained release pharmaceutical
dosages for therapeutic use. In doing so, Canntab has developed a suite of precision oral dose products that are unavailable
elsewhere in the marketplace. Canntab's primary focus is on providing cannabis-based products to medical professionals that can be
used to deliver therapeutic treatments to their patients.
FOR ADDITIONAL INFORMATION, PLEASE CONTACT:
Canntab Therapeutics Limited
Richard Goldstein, CFO
Office: 416 957-6303
Email: info@canntab.ca
Certain statements included in this press release constitute forward-looking information or statements (collectively,
"forward-looking statements"), including those identified by the expressions "anticipate", "believe", "plan", "estimate", "expect",
"intend", "may", "should" and similar expressions to the extent they relate to the Company or its management. The forward-looking
statements are not historical facts but reflect current expectations regarding future results or events. This press release
contains forward looking statements. These forward-looking statements are based on current expectations and various estimates,
factors and assumptions and involve known and unknown risks, uncertainties and other factors. Although management of the
Company has attempted to identify important factors that could cause actual results to differ materially from those contained in
forward-looking statements or forward-looking information, there may be other factors that cause results not to be anticipated,
estimated, or intended.
Neither the Canadian Securities Exchange (the "CSE") nor its Regulation Services Provider (as that term is defined in the
policies of the CSE) accepts responsibility for the adequacy or accuracy of this release.
